| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
2018-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109400692-B |
| titleOfInvention |
Specific short peptides, recombinant mesenchymal stem cells expressing specific short peptides and their applications |
| abstract |
The invention discloses a specific short peptide, recombinant mesenchymal stem cells expressing the specific short peptide and their applications. The present invention protects a polypeptide, as shown in SEQ ID NO: 1 of the Sequence Listing. Nucleic acid molecules encoding the polypeptides also fall within the scope of the present invention. The present invention also protects recombinant mesenchymal stem cells expressing the polypeptide. The present invention also protects a product whose active ingredient is any of the above-mentioned recombinant mesenchymal stem cells; the use of the product is to treat autoimmune diseases. The invention has great application value for the treatment of autoimmune diseases. |
| priorityDate |
2018-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |